Cardiovascular Business August 13, 2024
Siemens Healthineers has gained U.S. Food and Drug Administration (FDA) clearance for Acuson Origin, its new cardiovascular ultrasound system featuring advanced artificial intelligence (AI) capabilities
The Acuson Origin represents a significant update from the prior Siemens Healthineers cardiovascular ultrasound system, the Acuson SC2000. It includes algorithms designed to assist users with the treatment of diagnostic, structural heart, vascular, electrophysiological and pediatric patients. Its AI models can capture more than 5,000 measurements during transthoracic echocardiography and transesophageal echocardiography exams, recognize cardiac structures on its own without prompting, contour and quantify all four chambers of the heart and even anticipate what operators will want to do next.
The system also comes packaged with a 4D intracardiac echocardiography (ICE) catheter, the brand new...
Today's Sponsors
Today's Sponsor